These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28412)

  • 1. On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat.
    Al-Shabibi UM; Doggett NS
    J Pharm Pharmacol; 1978 Aug; 30(8):529-31. PubMed ID: 28412
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of brain norepinephrine in neuroleptic-induced catalepsy in rats.
    Honma T; Fukushima H
    Pharmacol Biochem Behav; 1977 Dec; 7(6):501-6. PubMed ID: 201939
    [No Abstract]   [Full Text] [Related]  

  • 3. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 4. Noradrenergic influences on catalepsy.
    Mason ST; Roberts DC; Fibiger HC
    Psychopharmacology (Berl); 1978 Dec; 60(1):53-7. PubMed ID: 104346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in drug induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4.
    Asin KE; Wirtshafter D; Fibiger HC
    Life Sci; 1982 May; 30(18):1531-6. PubMed ID: 7200562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of nomifensine.
    Maj J; Kapturkiewicz Z; Michaluk J
    Pol J Pharmacol Pharm; 1976; 28(6):557-62. PubMed ID: 189291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of alpha-adrenergic drugs on catalepsy induced by haloperidol or fluphenazine in rats.
    Wielosz M; Kleinrok Z; Włoch K; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1978; 30(5):653-8. PubMed ID: 35783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects.
    Anisman H; Ritch M; Sklar LS
    Psychopharmacology (Berl); 1981; 74(3):263-8. PubMed ID: 6791235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.
    Kataoka Y; Ohta H; Fujiwara M; Oishi R; Ueki S
    Neuropharmacology; 1987 Jan; 26(1):55-60. PubMed ID: 3031535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The neurochemical mechanisms of the formation and consolidation of haloperidol-induced catalepsy].
    Bazian AS; Getsova VM; Orlova NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(6):982-9. PubMed ID: 10693278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
    Jackson DM; Dunstan R; Perrington A
    J Neural Transm; 1979; 44(3):175-86. PubMed ID: 571456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat.
    Campbell A; Herschel M; Cohen BM; Baldessarini RJ
    Life Sci; 1980 Aug; 27(8):633-40. PubMed ID: 7191037
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of reserpine, tranylcypromine, haloperidol and FLA-63 on physostigmine--induced hyperactivity in rats.
    Wray SR; Egbe PC
    West Indian Med J; 1980 Mar; 29(1):60-6. PubMed ID: 7385820
    [No Abstract]   [Full Text] [Related]  

  • 17. Pilocarpine: noradrenergic mechanism of a cholinergic drug.
    Mason ST
    Neuropharmacology; 1978 Dec; 17(12):1015-21. PubMed ID: 570647
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiation between catalepsies induced by l-tetrahydropalmatine and by haloperidol and morphine (author's transl)].
    Xu J; Jin GZ; Yu LP; Liu XJ
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):152-5. PubMed ID: 6462002
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Biochemical evidence for the involvement of noradrenaline in motor activity produced by L-DOPA in rodents.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Oct; 55(2):292P. PubMed ID: 1201420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.